DIC: an update on diagnosis and treatment

Area of Science:

• Hematology
• Critical Care Medicine
• Infectious Diseases

Background:

• Disseminated intravascular coagulation (DIC) was historically viewed as a fatal condition.
• Emerging evidence suggests early-stage DIC may offer host protection against microthrombosis and infection.
• This challenges traditional early treatment protocols for DIC, particularly in sepsis patients.

Purpose of the Study:

• To highlight the increasing importance of accurate DIC diagnosis and timely treatment.
• To discuss the recently published Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG2016) concerning DIC.
• To compare and contrast DIC management recommendations between J-SSCG2016 and international guidelines.

Main Methods:

• Comparative analysis of treatment recommendations for DIC, including antithrombin and recombinant human thrombomodulin.
• Review of diagnostic criteria for DIC from various Japanese and international societies.
• Discussion of discrepancies in DIC management and diagnosis across different clinical practice guidelines.

Main Results:

• Significant differences exist in DIC treatment recommendations (e.g., antithrombin, thrombomodulin) between J-SSCG2016 and other major guidelines (JSTH, BCST, SISET, ISTH).
• Variations in diagnostic criteria for DIC are noted among Japanese (Ministry of Health, Labor and Welfare; Japanese Association for Acute Medicine; JSTH) and international (ISTH overt/non-overt) standards.
• The evolving understanding of DIC's role in sepsis necessitates a re-evaluation of diagnostic and therapeutic approaches.

Conclusions:

• The role of early DIC in sepsis warrants further investigation, potentially altering treatment paradigms.
• Discrepancies in guidelines underscore the need for harmonization in DIC diagnosis and management.
• Adherence to updated guidelines like J-SSCG2016 is crucial for optimizing patient outcomes in sepsis and DIC.